Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/824
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCostello, Anthony-
dc.contributor.authorCorcoran, Niall-
dc.contributor.authorHovens, Christopher-
dc.contributor.otherMangiola, Stefano-
dc.contributor.otherHong, Matthew-
dc.contributor.otherCmero, Marek-
dc.contributor.otherKurganovs, Natalie-
dc.contributor.otherRyan, Andrew-
dc.contributor.otherMacintyre, Geoff-
dc.date.accessioned2016-10-12T05:07:18Z-
dc.date.available2016-10-12T05:07:18Z-
dc.date.issued2016-09-
dc.identifier.citationSci Rep. 2016 Sep 22;6:33918.en_US
dc.identifier.issn2045-2322en_US
dc.identifier.urihttp://hdl.handle.net/11434/824-
dc.description.abstractThe role of lymph node metastases in distant prostate cancer dissemination and lethality is ill defined. Patients with metastases restricted to lymph nodes have a better prognosis than those with distant metastatic spread, suggesting the possibility of distinct aetiologies. To explore this, we traced patterns of cancer dissemination using tumour phylogenies inferred from genome-wide copy-number profiling of 48 samples across 3 patients with lymph node metastatic disease and 3 patients with osseous metastatic disease. Our results show that metastatic cells in regional lymph nodes originate from evolutionary advanced extraprostatic tumour cells rather than less advanced central tumour cell populations. In contrast, osseous metastases do not exhibit such a constrained developmental lineage, arising from either intra or extraprostatic tumour cell populations, at early and late stages in the evolution of the primary. Collectively, this comparison suggests that lymph node metastases may not be an intermediate developmental step for distant osseous metastases, but rather represent a distinct metastatic lineage.en_US
dc.publisherNature Publishing Groupen_US
dc.relation.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031992/pdf/srep33918.pdf-
dc.subjectLymph Nodesen_US
dc.subjectMetastasesen_US
dc.subjectProstate Canceren_US
dc.subjectAetiologyen_US
dc.subjectCancer Disseminationen_US
dc.subjectLymph Node Metastatic Diseaseen_US
dc.subjectOsseous Metastatic Diseaseen_US
dc.subjectTumour Phylogeniesen_US
dc.subjectComparisonen_US
dc.subjectThe Epworth Prostate Centre, Epworth Hospital, Victoria, Australia.en_US
dc.subjectCancer Services Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleComparing nodal versus bony metastatic spread using tumour phylogenies.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1038/srep33918en_US
dc.identifier.journaltitleScientific Reportsen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/27653089en_US
dc.description.affiliatesDepartments of Urology and Surgery, Royal Melbourne Hospital and University of Melbourne, Parkville 3050 Victoria, Australia.en_US
dc.description.affiliatesCentre for Neural Engineering, 203 Bouverie St, Carlton 3053, Victoria, Australia.en_US
dc.description.affiliatesTissuPath Specialist Pathology, Mount Waverley 3149, Victoria, Australia.en_US
dc.description.affiliatesCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.en_US
dc.type.studyortrialComparative Studyen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
Epworth Prostate Centre

Files in This Item:
File Description SizeFormat  
Comparing nodal versus bony metastatic spread using tumour phylogenies.pdf1.22 MBAdobe PDFView/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.